Smoking cessation can correct cardiovascular abnormalities related to smoking, though success rates are low, highlighting the need for best practice treatment in smokers unable to quit.
Does smoking cessation improve cardiovascular risk factors and reduce cardiovascular disease in smokers?
Smoking cessation is essential to correct cardiovascular risk factors, and smokers who cannot quit should receive optimal guideline-directed medical therapy to minimize adverse cardiovascular effects.
Cigarette smoking, active or passive, kills about 6 million people each year worldwide. Cardiovascular disease (CVD) is responsible for 40% of all smoking-related deaths, lung cancer accounts for 20% of all smoking-related deaths, and chronic obstructive pulmonary disease is related to another 20% of deaths. In this narrative review we consider the relationship between cigarette smoking and CVD. We discuss disease states and/or CVD risk factors related to smoking, such as dyslipidaemia, vascular inflammation, endothelial dysfunction, arterial stiffness, insulin resistance, type 2 diabetes mellitus (T2DM), chronic kidney disease (CKD), and non-alcoholic fatty liver disease (NAFLD) as well as their complex interrelations. Smoking cessation can correct abnormalities related to smoking; however, success rates are relatively low. In cases of inability to quit, measures to minimize the adverse effects of smoking specifically related to CVD should be taken. Smokers should receive best practice treatment, according to guidelines, as for non-smokers.
Athyros et al. (Wed,) conducted a review in Cardiovascular disease and smoking. Tobacco smoking and smoking cessation was evaluated. Smoking cessation can correct cardiovascular abnormalities related to smoking, though success rates are low, highlighting the need for best practice treatment in smokers unable to quit.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: